NCT04804241View on ClinicalTrials.gov

Senicapoc in Alzheimer's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Mild Cognitive ImpairmentAlzheimer Disease
Interventions
DRUG

Senicapoc

10 mg oral tablet

OTHER

Placebo Tablet

Placebo Oral Tablet

Trial Locations (2)

94598

RECRUITING

UC Davis Alzheimer's Disease Center East Bay, Walnut Creek

95817

RECRUITING

University of California, Davis Alzheimer's Disease Center, Sacramento

Sponsors

Collaborators (1)

Biossil Inc.
All Listed Sponsors
collaborator

Alzheimer's Drug Discovery Foundation

OTHER

collaborator

Alzheimer's Association

OTHER

collaborator

Biossil Inc.

INDUSTRY

lead

University of California, Davis

OTHER